AnalystsJason N. ButlerJason N. Butler's Stock Forecasts
AnalystsJason N. Butler
Sectors:
Industries:
Analyst Ranking
Bottom 18%
#4254 out of 5156 analysts
Average Return
-3.16%
Win Rate
50%5 out of 10
Risk vs Reward
Poor
Good
Jason N. Butler's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Abivax SaABVX | +35.15% | $82.00 | $110.82 | 2025-09-24 - 2025-12-17 | Buy |
Precigen IncPGEN | +23.60% | $3.22 | $3.98 | 2025-08-18 - 2025-12-17 | Buy |
Cytokinetics IncCYTK | +20.56% | $49.62 | $59.82 | 2025-09-01 - 2025-12-17 | Buy |
Rapport Therapeutics IncRAPP | +11.77% | $25.66 | $28.68 | 2025-11-06 - 2025-12-17 | Buy |
Acadia Pharmaceuticals IncACAD | +10.37% | $24.40 | $26.93 | 2025-08-06 - 2025-12-17 | Buy |
Jason N. Butler Analyst Color
Get additional color on Jason N. Butler's coverage of popular stocks
Jason N. Butler's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Achieve Life Sciences IncACHV | 1 | Buy | $19.00 | +349.17% | Initiates Coverage On | 23 days ago |
Rapport Therapeutics IncRAPP | 1 | Buy | $80.00 | +178.94% | Maintains | a month ago |
Terawulf IncWULF | 1 | Buy | $22.00 | +90.15% | Maintains | 2 months ago |
Rezolute IncRZLT | 1 | Buy | $17.00 | +745.77% | Maintains | 2 months ago |
Abivax SaABVX | 1 | Buy | $114.00 | +2.87% | Maintains | 3 months ago |
Cormedix IncCRMD | 1 | Buy | $22.00 | +92.14% | Reiterates | 3 months ago |
Cytokinetics IncCYTK | 1 | Buy | $78.00 | +30.39% | Reiterates | 4 months ago |
Precigen IncPGEN | 1 | Buy | $8.00 | +101.01% | Maintains | 4 months ago |
Zevra Therapeutics IncZVRA | 1 | Buy | $18.00 | +121.95% | Maintains | 4 months ago |
Acadia Pharmaceuticals IncACAD | 1 | Buy | $35.00 | +29.97% | Maintains | 4 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.